Question 1

How might carbidopa-levodopa help with my spasticity compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis clinical trial (NCT03929068). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis clinical trial (NCT03929068). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis clinical trial (NCT03929068). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the treatment period?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis clinical trial (NCT03929068). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis clinical trial (NCT03929068). Contact the study team or your healthcare provider for specific answers.

What this study is about